Research graph
References from Geographical Variation in Antimalarial Drug Resistance Marker Prevalence across the Southern African Elimination Eight Region. Local targets link to admitted publications; unresolved targets remain external evidence.
Impact of the COVID-19 pandemic on malaria control in Africa: A preliminary analysis
2023 · External reference
World Malaria Report 2024: Addressing Inequity in the Global Malaria Response
2024 · External reference
World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance
2025 · External reference
The emergence of artemisinin partial resistance in Africa: How do we respond?
2024 · External reference
The public health impact of chloroquine resistance in Africa
2001 · External reference
Reviewing South Africa’s malaria elimination strategy (2012–2018): Progress, challenges and priorities
2016 · External reference
Spread of chloroquine resistance in Plasmodium falciparum
1987 · External reference
Intercontinental spread of pyrimethamine-resistant malaria
2004 · External reference
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum
2002 · External reference
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
2015 · External reference
Global Technical Strategy for Malaria 2016–2030, 2021 Update
2021 · External reference
Strategy to Respond to Antimalarial Drug Resistance in Africa
2022 · External reference
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites
2024 · External reference
Understanding the global rise of artemisinin resistance: Insights from over 100,000 Plasmodium falciparum samples
2025 · External reference
Malaria Threat Map
2026 · External reference
Eliminating malaria from the margins of transmission in Southern Africa through the Elimination 8 Initiative
2021 · External reference
Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: Protocol
2022 · External reference
Malaria Atlas Project Pf Incidence Rate 2023
2026 · External reference
A Framework for Malaria Elimination
2017 · External reference
Geographical heterogeneity in antimalarial resistance markers by genomic surveillance in Angola, 2023
2026 · External reference
Genomic surveillance reveals clusters of Plasmodium falciparum antimalarial resistance markers in Eswatini, a low-transmission setting
2026 · External reference
High prevalence of molecular markers associated with artemisinin, sulphadoxine and pyrimethamine resistance in northern Namibia
2025 · External reference
Very low prevalence of validated kelch13 mutations and absence of histidine-rich protein 2/3 double gene deletions in South African malaria-eliminating districts (2022–2024)
2025 · External reference
Plasmodium falciparum genomic surveillance reveals a diversity of Kelch13 mutations in Zambia
2025 · External reference
Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities in 2021 and 2022
2025 · External reference
National Malaria Elimination Strategic Plan 2022–2026
2022 · External reference
Seasonal malaria chemoprevention in northern Mozambique: A cost-effectiveness analysis
2025 · External reference
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin–piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: A pragmatic cluster randomised controlled trial
2021 · External reference
Impact of four rounds of mass drug administration with dihydroartemisinin–piperaquine implemented in Southern Province, Zambia
2020 · External reference
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: A cluster-randomised controlled, open-label, two-by-two factorial design trial
2020 · External reference
Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health
2025 · External reference
Optimization of whole-genome sequencing of Plasmodium falciparum from low-density dried blood spot samples
2021 · External reference
Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets
2015 · External reference
Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women
2009 · External reference
The Portable Microhaplotype Object and Tools.
10.64898/2025.12.10.693568 · 2025 · External reference
A worldwide map of Plasmodium falciparum K13-propeller polymorphisms
2016 · External reference
Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010–2019)
2020 · External reference
Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania
2002 · External reference
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in Northern Tanzania and the emergence of dhps resistance mutation at codon 581
2009 · External reference
A molecular marker for chloroquine-resistant falciparum malaria
2001 · External reference
Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
2020 · External reference
Changing antimalarial drug sensitivities in Uganda
2017 · External reference
Compendium of Molecular Markers for Antimalarial Drug Resistance
2025 · External reference
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: A phenotype–genotype association study
2017 · External reference
Genetic architecture of artemisinin-resistant Plasmodium falciparum
2015 · External reference
Evolution of partial resistance to artemisinins in malaria parasites in Uganda
2023 · External reference
Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: A modelling study
2025 · External reference
Artemisinin partial resistance mutations in Zanzibar and Tanzania suggest regional spread and African origins, 2023
2026 · External reference
The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant Plasmodium falciparum
2022 · External reference
The provision of malaria services in border districts of four countries in Southern Africa: Results from a cross-sectional community assessment of malaria border health posts
2023 · External reference
Surveillance and response for high-risk populations: What can malaria elimination programmes learn from the experience of HIV?
2017 · External reference
The transit phase of migration: Circulation of malaria and its multidrug-resistant forms in Africa
2011 · External reference
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: Parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine
2014 · External reference
Drug susceptibility of Plasmodium falciparum in eastern Uganda: A longitudinal phenotypic and genotypic study
2021 · External reference
A Novel Locus Associated with Decreased Susceptibility of Plasmodium falciparum to Lumefantrine and Dihydroartemisinin Has Emerged and Spread in Uganda.
10.1101/2025.07.30.667738 · 2025 · External reference
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
2025 · External reference
Therapeutic response to four artemisinin-based combination therapies in Angola, 2021
2024 · External reference
Artemether-lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections
2025 · External reference
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
2024 · External reference
Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
2022 · External reference
The impact of sulfadoxine–pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: An updated systematic review and meta-analysis
2025 · External reference
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: Systematic review and meta-analysis
2015 · External reference
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
2014 · External reference
Emergence and Spread of Artemisinin-Resistant Malaria in Zambia
10.64898/2026.06.04.26354343 · 2026 · External reference
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
2023 · External reference
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
2023 · External reference
